This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Masako Kuno: Innovator in Imidazole Compounds
Introduction
Masako Kuno is a notable inventor based in Amagasaki, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his work on imidazole compounds. His innovative research focuses on compounds that have potential therapeutic applications.
Latest Patents
Masako Kuno holds a patent for imidazole compounds that exhibit adenosine deaminase inhibitory activity. The patent describes compounds represented by a specific formula, where various substituents can be hydrogen, hydroxy, or aryl, among others. These compounds are particularly useful for treating and preventing diseases where adenosine plays a crucial role.
Career Highlights
Kuno is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been instrumental in advancing pharmaceutical research. His work has led to the development of novel compounds that could significantly impact therapeutic strategies.
Collaborations
Throughout his career, Masako Kuno has collaborated with esteemed colleagues such as Tadashi Terasaka and Katsuya Nakamura. These collaborations have fostered a productive research environment, leading to innovative discoveries in the field.
Conclusion
Masako Kuno's contributions to the development of imidazole compounds highlight his role as a key innovator in medicinal chemistry. His work continues to pave the way for advancements in treating diseases related to adenosine.